DCVC Opportunity Fund II GP, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, DCVC Opportunity Fund II GP, LLC held in its portfolio 2 assets valued at $16,587,374 (i.e. $16.59M).

The most valuable assets in the portfolio included: Recursion Pharmaceuticals, Inc. ($16.16M), and IonQ, Inc. ($427.21K),

The chart below shows the top 2 valuable assets, and the table below shows the top 2 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in DCVC Opportunity Fund II GP, LLC Portfolio

Recursion Pharmaceuticals, Inc.

IonQ, Inc.

DCVC Opportunity Fund II GP, LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
Recursion Pharmaceuticals, Inc.	3951141	16160167	CL A
IonQ, Inc.	9521	427207	CL A